title: [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
abstract: The number of patients suffering from autoimmune diseases is increasing and the prognosis of the patients is improving. The article gives an overview of the present status of immunomodulatory therapies. The author deals with the non-specific and the selective forms of immunosuppression. He gives a short summary about biological treatments, the induction of tolerability and about anti-cytokine therapies, In this review the modern treatment strategies of rheumatoid arthritis are also discussed, among them the early, the combined, the antigen-specific and the stem cell treatment modalities are detailed. It is emphasised that the individual differences are important to take into consideration in the treatment of autoimmune diseases.
authors.affiliation: Debreceni Egyetem, Orvos-és Egészségtudományi Centrum, Belgyógyászati Intézet. szegedi@iiibel.dote.hu
authors.forename: Gyula
authors.initials: G
authors.lastname: Szegedi
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology* / Q000628:therapy; D016207:Cytokines / Q000037:antagonists & inhibitors* / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology; D009930:Organic Chemicals; D013234:Stem Cells
chemical_list: D016207:Cytokines; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D009930:Organic Chemicals; C029248:Tolerogen